Star Bulk Carriers Corp vs TG Therapeutics Inc — how do they compare? Star Bulk Carriers Corp trades at $26.32 (market cap $2.91B), while TG Therapeutics Inc trades at $54.06 (market cap $8.26B). The key difference: TG Therapeutics Inc is far larger — about 2.8× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 3.95% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SBLK | TGTX | |
|---|---|---|
Market Cap | $2.91B | $8.26B |
Sector | Industrials | Health |
52-Week High | $28.21 | $59.06 |
52-Week Low | $16.79 | $26.39 |
Enterprise Value | $3.61B | $8.50B |
Dividend Yield | 3.95% | — |
Trailing returns across standard periods
Latest headlines on both assets
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →